Insider Trading Alert - NEWP, WWAV And WMGI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 19, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,088.06 to $96,569,200.00.

Highlighted Stocks Traded by Insiders:

Newport (NEWP) - FREE Research Report

Allen David J, who is SVP & GM, Lasers Group at Newport, sold 6,500 shares at $19.27 on May 19, 2015. Following this transaction, the SVP & GM, Lasers Group owned 58,503 shares meaning that the stake was reduced by 10% with the 6,500-share transaction.

The shares most recently traded at $19.07, down $0.20, or 1.06% since the insider transaction. Historical insider transactions for Newport go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 21,250

The average volume for Newport has been 145,300 shares per day over the past 30 days. Newport has a market cap of $772.6 million and is part of the technology sector and electronics industry. Shares are unchanged year-to-date as of the close of trading on Tuesday.

Newport Corporation, together with its subsidiaries, provides technology products and systems for scientific research, microelectronics, defense and security, life and health sciences, and industrial markets worldwide. The company operates in three groups: Photonics, Lasers, and Optics. The company has a P/E ratio of 21.8. Currently, there are 4 analysts who rate Newport a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NEWP - FREE

TheStreet Quant Ratings rates Newport as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Newport Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Whitewave Foods Company (WWAV) - FREE Research Report

Fugger Edward F, who is Executive Vice President at Whitewave Foods Company, sold 21,000 shares at $47.74 on May 19, 2015. Following this transaction, the Executive Vice President owned 41,417 shares meaning that the stake was reduced by 33.64% with the 21,000-share transaction.

The shares most recently traded at $47.52, down $0.22, or 0.46% since the insider transaction. Historical insider transactions for Whitewave Foods Company go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 4,011
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 4,011
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 4,011

The average volume for Whitewave Foods Company has been 1.7 million shares per day over the past 30 days. Whitewave Foods Company has a market cap of $8.3 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 35.18% year-to-date as of the close of trading on Tuesday.

The WhiteWave Foods Company, a consumer packaged food and beverage company, manufactures, markets, distributes, and sells branded plant-based foods and beverages, salads, fruits and vegetables, coffee creamers and beverages, and dairy products and organic produce in North America and Europe. The company has a P/E ratio of 59.5. Currently, there are 12 analysts who rate Whitewave Foods Company a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WWAV - FREE

TheStreet Quant Ratings rates Whitewave Foods Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Whitewave Foods Company Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Wright Medical Group (WMGI) - FREE Research Report

Andrews Julie, who is VP Fin. & Chief Acctg. Officer at Wright Medical Group, sold 680 shares at $26.22 on May 19, 2015. Following this transaction, the VP Fin. & Chief Acctg. Officer owned 14,506 shares meaning that the stake was reduced by 4.48% with the 680-share transaction.

The shares most recently traded at $26.07, down $0.15, or 0.58% since the insider transaction. Historical insider transactions for Wright Medical Group go as follows:

  • 4-Week # shares sold: 16,669
  • 12-Week # shares sold: 19,525
  • 24-Week # shares sold: 19,525

The average volume for Wright Medical Group has been 1.1 million shares per day over the past 30 days. Wright Medical Group has a market cap of $1.3 billion and is part of the health care sector and health services industry. Shares are down 3.09% year-to-date as of the close of trading on Tuesday.

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles worldwide. Currently, there are 7 analysts who rate Wright Medical Group a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WMGI - FREE

TheStreet Quant Ratings rates Wright Medical Group as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Wright Medical Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists